CHEK1 |
CHEK1, CHK1: Serine/threonine-protein kinase Chk1 |
CCNA2 |
CCNA2, CCN1, CCNA: Cyclin-A2 |
31.410 |
Evidence |
|
CDK4 |
CDK4: Cell division protein kinase 4 |
CCNA2 |
CCNA2, CCN1, CCNA: Cyclin-A2 |
31.410 |
Evidence |
|
CCNA2 |
CCNA2, CCN1, CCNA: Cyclin-A2 |
CDK2 |
CDK2: Cell division protein kinase 2 |
31.410 |
Evidence |
O
|
KHDRBS1 |
KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate |
DOK1 |
DOK1: Docking protein 1 |
31.290 |
Evidence |
|
HGS |
HGS, HRS: Hepatocyte growth factor-regulated tyrosine kinase substrate |
STAM2 |
STAM2: Signal transducing adapter molecule 2 |
31.280 |
Evidence |
|
F2 |
F2: Prothrombin precursor |
LOC641705 |
AMY2A: Pancreatic alpha-amylase precursor |
31.280 |
Evidence |
|
F9 |
F9: Coagulation factor IX precursor |
LOC641705 |
AMY2A: Pancreatic alpha-amylase precursor |
31.280 |
Evidence |
|
EFNA4 |
EFNA4, EPLG4, LERK4: Ephrin-A4 precursor |
EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
31.250 |
Evidence |
|
EFNA5 |
EFNA5, EPLG7, LERK7: Ephrin-A5 precursor |
EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
31.250 |
Evidence |
|
EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
EFNB3 |
EFNB3, EPLG8, LERK8: Ephrin-B3 precursor |
31.250 |
Evidence |
|
EFNA3 |
EFNA3, EFL2, EPLG3, LERK3: Ephrin-A3 precursor |
EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
31.250 |
Evidence |
|
MCM4 |
MCM4, CDC21: DNA replication licensing factor MCM4 |
CCNH |
CCNH: Cyclin-H |
31.240 |
Evidence |
|
VIL2 |
IPI00479359 |
CDK7 |
CDK7, MO15: Cell division protein kinase 7 |
31.240 |
Evidence |
|
GRIN2A |
GRIN2A, NMDAR2A: Glutamate [NMDA] receptor subunit epsilon-1 precursor |
GRIN2B |
GRIN2B, NMDAR2B: Glutamate [NMDA] receptor subunit epsilon-2 precursor |
31.240 |
Evidence |
|
ADRBK1 |
ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 |
RASA3 |
RASA3: Ras GTPase-activating protein 3 |
31.240 |
Evidence |
|
NRAS |
NRAS, HRAS1: GTPase NRas precursor |
AKT1 |
AKT1, PKB, RAC: RAC-alpha serine/threonine-protein kinase |
31.240 |
Evidence |
|
PRKCI |
PRKCI, DXS1179E: Protein kinase C iota type |
STK24 |
STK24, MST3, STK3: Serine/threonine-protein kinase 24 |
31.240 |
Evidence |
|
CEBPB |
CEBPB, TCF5, PP9092: CCAAT/enhancer-binding protein beta |
CREBBP |
CREBBP, CBP: CREB-binding protein |
31.240 |
Evidence |
|
CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
DOK1 |
DOK1: Docking protein 1 |
31.240 |
Evidence |
|
MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
31.240 |
Evidence |
O
|
RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
DAPK1 |
DAPK1, DAPK: Death-associated protein kinase 1 |
31.240 |
Evidence |
|
PIK3CG |
PIK3CG: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma i |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
31.240 |
Evidence |
|
RPS6KB1 |
IPI00216132 |
DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
31.240 |
Evidence |
|
KLF1 |
KLF1, EKLF: Krueppel-like factor 1 |
HDAC2 |
HDAC2: Histone deacetylase 2 |
31.240 |
Evidence |
|
DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
31.240 |
Evidence |
|